Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study of Stable Haemodialysis Patients Switched From Darbepoetin Alfa to Epoetin Alfa Biosimilar

NCT02191150 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02191150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02191150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study of Stable Haemodialysis Patients Switched From Darbepoetin Alfa to Epoetin Alfa Biosimilar
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
May 31, 2015
Enrollment
272 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia